1.
|
Phase: Phase IV Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and under Sponsor: NICHD Protocol IDs: PPRU 10762, NCT00491946
|
|
2.
|
Phase: Phase III Type: Treatment Status: Active Age: Under 30 Sponsor: NCI, Other Protocol IDs: CDR0000496508, COG-AREN0533, AREN0533, NCT00379340
|
|
3.
|
Phase: Phase III Type: Supportive care, Treatment Status: Active Age: Under 30 at initial diagnosis Sponsor: NCI, Other Protocol IDs: CDR0000649716, COG-AREN0534, AREN0534, NCT00945009
|
|
4.
|
Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 2 to 20 Sponsor: NCI, Pharmaceutical / Industry Protocol IDs: 100220, IND 59,056, NCT01222780
|
|
5.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: Under 30 Sponsor: NCI, Other Protocol IDs: AREN0321, CDR0000472893, COG-AREN0321, NCT00335556
|
|
6.
|
Phase: Phase II Type: Treatment Status: Active Age: 3 to 55 Sponsor: Other Protocol IDs: 2009-0528, NCT01277744
|
|
7.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 1 and over Sponsor: Other Protocol IDs: 09-090, NCT01099644
|
|
8.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 2 to 21 Sponsor: Other Protocol IDs: SorIrin1576, NCT01518413
|
|
9.
|
Phase: Phase I Type: Treatment Status: Active Age: 2 to 21 Sponsor: Other Protocol IDs: RADIANT, NCT01625351
|
|
10.
|
Phase: No phase specified Type: Treatment Status: Active Age: 70 and under Sponsor: Other Protocol IDs: 2011OC057, MT2011-09C, NCT01505569
|
|
11.
|
Phase: No phase specified Type: Treatment Status: Active Age: 1 to 29 Sponsor: NCI, Other Protocol IDs: Lung IMRT, NCT01586104
|